While the coronavirus has impacted millions of Americans across the United States, it has hit the elderly population particularly hard. In fact, more than 40 percent of coronavirus deaths in the U.S. have been linked to long-term care facilities, according to a New York Times survey. In an effort to bring those numbers down, pharmaceutical company Eli Lilly, in partnership with the National Institutes of Health (NIH), has just launched a late-stage antibody treatment trial focusing on residents and staff at nursing homes.
"COVID-19 has had a devastating impact on nursing home residents," Lilly's chief scientific officer Daniel Skovronsky said in a statement. "We're working as fast as we can to create medicines that might stop the spread of the virus to these vulnerable individuals."
The trial is expected to enroll up to 2,400 participants who live or work at a facility and have recently been diagnosed with the disease. The trial will evaluate the safety and success of using LY-CoV555, a potent, neutralizing antibody that works against the spike protein of the novel coronavirus. The trial will look at whether a single dose of the antibody treatment reduces the rate of infection over four weeks as well as symptoms over eight weeks.
"The importance of these kinds of therapies for people like the elderly or immunocompromised is that they can provide the hope and the safety net that these people really need right now," said Andrew Adams, vice president of new therapeutic modalities & COVID-19 research at Eli Lilly, who is overseeing the trial. "I think people in those populations are really desperate and looking for something to help with the coronavirus."
Eli Lilly is taking its trial on the road with customized mobile research units that can travel directly to areas that are experiencing outbreaks.
"This is an interesting solution, to bring the medicine to these vulnerable patients," said Adams. "This lets us be flexible and move these trials around the country, tracking these trials as we come across them."
Adams said he is hoping Eli Lilly will have results on the efficacy of these antibodies in the fourth quarter of this year. Even if successful, though, he says research for a vaccine needs to continue.
"These have to be thought of as more of a bridge, where a vaccine provides long-term protection in terms of years of immunity, where we will provide hopefully in the range of months with these types of treatments. We hope this to be a short-term bridge to the long-term effective vaccination," he said.
NASA is gearing up this week for a mission to launch a SpaceX Falcon 9 rocket into a near-Earth asteroid in an attempt to move it slightly off its projected course. Thomas Zurbuchen, an associate administrator for the NASA Science Mission Directorate, joined Cheddar's "Opening Bell" to provide some additional details about the Double Asteroid Redirection Test (DART) and explained why it is necessary as a means to protect Earth.
With Thanksgiving two days away, the USDA is reminding hosts of the importance of food safety. Karen Hunter, Food Safety Expert, USDA, joined Cheddar's Opening Bell to discuss the best food handling and leftover tips ahead of the holiday.
Jill and Carlo are a bit delayed today on account of Carlo's internet not working. Better late than never, they discuss what we know about the suspect in the Christmas parade crash, closing arguments in the Arbery killing trial, and more.
If you’ve ever watched a show or movie where a character is unconscious for some reason - drowning, electrocution, stabbed in a knife fight - you probably know what to expect next. Some hero will come perform what looks like cardiopulmonary resuscitation (CPR) for a minute or two, perhaps in slow motion, and definitely with a dramatic musical score. And bing, bang, boom, the unconscious character miraculously comes back to life.
If you’ve ever suspected that this is a gross exaggeration of the efficacy of CPR, well, you’re right. But exactly how wrong Hollywood gets CPR is hilarious at best and downright dangerous at worst.
Countries around the world continue to grapple with rising COVID cases, with Germany confirming case numbers at their highest at any point during the pandemic. German officials say that 48,000 new cases are being reported everyday.
Jill and Carlo cover the developing story out of suburban Milwaukee, where a speeding SUV careened through a Christmas parade. Looters get more brazen in San Francisco, the missing Chinese tennis star resurfaces, and more.
A CDC panel has unanimously endorsed boosters of the Pfizer and Moderna COVID-19 vaccines for all adults. Internal medicine physician Dr. Vivek Cherian joined Cheddar News to weigh in.
Neuroscientist Dr. Bankole Johnson joined Cheddar News to talk about the expectation of boosters for all U.S. adults and what the move would mean in the fight against the pandemic.
Deborah Sass, CO-CEO and Founding Partner of Space Hero, joins ChedHER to discuss how she's creating a global competition to send someone on a 10-day trip to space, her experience in the space industry without a background in STEM, and how she hopes to inspire younger generations of women.
